AKT1 and breast carcinoma: Guajadial may be a viable strategy for overcoming drug resistance during chemotherapy of breast cancer, according to Li et al.’s findings that treatment with Guajadial suppressed the activation of the PI3K/Akt pathway in drug-resistant breast cancer cells [31].